For example, the acquisition of an SRSF2 mutation in a clone harboring a pre-existing TET2 mutation often results in a tendency to develop a high risk MDS/MPN disease, often with monocytosis [36]. This evidence concerns the gene SRSF2 and myelodysplastic syndrome.